Enhancement of development of azoxymethane-induced colonic premalignant lesions in C57BL/KsJ-db/db mice

Carcinogenesis

Volumn 25, Issue 5, 2004, Pages 821-825

  Hirose, Yoshinobu ^c   Hata, Kazuya ^c   Kuno, Toshiya ^c   Yoshida, Koujiro ^c   Sakata, Keiko ^c   Yamada, Yasuhiro ^c   Tanaka, Takuji ^a   Reddy, Bandaru S ^b   Mori, Hideki ^c  

^a KANAZAWA MEDICAL UNIVERSITY   (Japan)

^b AMERICAN HEALTH FOUNDATION   (United States)

^c GIFU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

AZOXYMETHANE; CARCINOGEN; GLUCOSE; INSULIN; LEPTIN; LEPTIN RECEPTOR; SOMATOMEDIN C RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD LEVEL; BODY WEIGHT; CHRONIC DISEASE; COLON CARCINOGENESIS; CONTROLLED STUDY; DIABETES MELLITUS; DIET RESTRICTION; DISEASE ASSOCIATION; DYSPLASIA; GLUCOSE BLOOD LEVEL; HETEROZYGOTE; HOMOZYGOSITY; IMMUNOHISTOCHEMISTRY; INSULIN BLOOD LEVEL; MALE; MOUSE; MOUSE STRAIN; NONHUMAN; OBESITY; PHENOTYPE; PRECANCER; PRIORITY JOURNAL; UPREGULATION;

ANIMALS; AZOXYMETHANE; BLOOD GLUCOSE; BODY WEIGHT; CARCINOGENS; COLONIC NEOPLASMS; DIABETES MELLITUS, EXPERIMENTAL; HETEROZYGOTE; HOMOZYGOTE; HYPERINSULINISM; IMMUNOBLOTTING; INSULIN; LEPTIN; MALE; MICE; MICE, INBRED C57BL; MICE, OBESE; OBESITY; PRECANCEROUS CONDITIONS; RECEPTOR, IGF TYPE 1; RECEPTORS, CELL SURFACE;

EID: 2442497348     PISSN: 01433334     EISSN: None     Source Type: Journal    
DOI: 10.1093/carcin/bgh059     Document Type: Article

References (40)

1. Murphy,T.K., Calle,E.E., Rodriguez,C., Kahn,H.S. and Thun,M.J. (2000) Body mass index and colon cancer mortality in a large prospective study. Am. J. Epidemiol., 152, 847-854.
2. Bergstrom,A., Pisani,P., Tenet,V., Wolk,A. and Adami,H.-O. (2001) Overweight as an avoidable cause of cancer in Europe. Int. J. Cancer, 91, 421-430.
3. Bray,G.A. (2002) The underlying basis for obesity: relationship to cancer. J. Nutr., 132, 3451S-3455S.
4. Willett,C.W. (2000) Diet and cancer. Oncologist, 5, 393-404.
5. Friedenreich,C.M. and Orenstein,M.R. (2002) Physical activity and cancer prevention: etiologic evidence and biological mechanisms. J. Nutr., 132, 3456S-3464S.
6. Campbell,S. and Ghosh,S. (2002) Ulcerative colitis and colon cancer: strategies for cancer prevention. Dig. Dis., 20, 38-48.
7. Jass,J.R. (2000) Familial colorectal cancer: pathology and molecular characteristics. Lancet Oncol., 1, 220-226.
8. Reddy,B.S. (1995) Nutritional factors and colon cancer. Crit. Rev. Food Sci. Nutr., 35, 175-190.
9. Reddy,B.S., Sugie,S. and Lowenfels,A. (1988) Effect of voluntary exercise on azoxymethane-induced colon carcinogenesis in male F344 rats. Cancer Res., 15, 7079-7081.
10. Potter,J.D. (1999) Colorectal cancer: molecules and populations. J. Natl Cancer Inst., 91, 916-932.
11. Fruhbeck,G. and Gomez-Ambrosi,J. (2001) Rationale for the existence of additional adipostatic hormones. FASEB J., 15, 1996-2006.
12. Lee,G.H., Proenca,R., Montez,J.M., Carroll,K.M., Darvishzadeh,J.G., Lee,J.I. and Friedman,J.M. (1996) Abnormal splicing of the leptin receptor in diabetic mice. Nature, 379, 632-635.
13. Margetic,S., Gazzola,C., Pegg,G.G. and Hill,R.A. (2002) Leptin: a review of its peripheral actions and interactions. Int. J. Obes. Relat. Metab. Disord., 26, 1407-1433.
14. Tsuchiya,T., Shimizu,H., Horie,T. and Mori,M. (1999) Expression of leptin in lung: leptin as a growth factor. Eur. J. Pharmacol., 365, 273-279.
15. Dieudonne,M.N., Machinal-Quelin,F., Serazin-Leroy,V., Leneveu,M.C., Pecquery,R. and Giudicelli,Y. (2002) Leptin mediates a proliferative response in human MCF7 breast cancer cells. Biochem. Biophys. Res. Commun., 293, 622-628.
16. Hardwick,J.C.H., van den Brink,G.R., Offerhaus,G.J., van Deventer,J.H. and Peppelenbosch,M.P. (2001) Leptin is a growth factor for colonic epithelial cells. Gastroenterology, 121, 79-90.
17. O'Brien,S.N., Welter,B.H. and Price,T.M. (1999) Presence of leptin in breast cell lines and breast tumors. Biochem. Biophys. Res. Commun., 259, 695-699.
18. Mix,H., Jandl,O., Cornberg,M., Kaul,A., Goke,M., Manns,M.P. and Wagner,S. (2000) Expression of leptin and leptin receptor isoforms in the human stomach. Gut, 47, 481-486.
19. Nakao,T., Hino,M., Yamane,T., Nishizawa,Y., Morii,H. and Tatsumi,N. (1998) Expression of the leptin receptor in human leukaemic blast cells. Br. J. Haematol., 102, 740-745.
20. Hirose,Y., Kuno,T., Yamada,Y., Sakata,K., Katayama,K., Yoshida,K., Zheng,Q., Hata,K. and Mori,H. (2003) Azoxymethane-induced beta-catenin-accumulated crypts in colonic mucosa of rodents as a intermediate biomarker for colon carcinogenesis. Carcinogenesis, 24, 107-111.
21. Chang,W.W.L. (1984) Histogenesis of colon cancer in experimental animals. Scand. J. Gastroenterol., 104 (suppl.), 27-43.
22. Risio,M., Lipkin,M., Newmark,H., Yang,K., Rossini,F.P., Steele,V.E., Boone,C.W. and Kelloff,G.J. (1996) Apoptosis, cell replication and western-style diet-induced tumorigenesis in mouse colon. Cancer Res., 56, 4910-4916.
23. Wynder,E.L. and Gori,G.B. (1977) Contribution of the environment to cancer incidence: an epidemiologic exercise. J. Natl Cancer Inst., 58, 825-832.
24. Doll,R. and Peto,R. (1981) The causes of cancer: quantitative estimates of avoidable risks of cancer in the United States today. J. Natl Cancer Inst., 66, 1191-1308.
25. Weber,R.V., Stein,D.E., Scholes,J. and Kral,J.G. (2000) Obesity potentiates AOM-induced colon cancer. Dig. Dis. Sci., 45, 890-895.
26. Lee,W.M., Lu,S., Medline,A. and Archer,M.C. (2001) Susceptibility of lean and obese Zucker rats to tumorigenesis induced by N-methyl-N-nitrosourea. Cancer Lett., 162, 155-160.
27. Hu,X., Juneja,S.C., Maihle,N.J. and Cleary,M.P. (2002) Leptin - a growth factor in normal and malignant breast cells and for normal mammary gland development. J. Natl Cancer Inst., 94, 1704-1711.
28. Murakami,T., Yamashita,T., Iida,M., Kuwajima,M. and Shima,K. (1997) A short form of leptin receptor performs signal transduction. Biochem. Biophys. Res. Commun., 231, 26-29.
29. Madiehe,A.M., Hebert,S., Mitchell,T.D. and Harris,R.B.S. (2002) Strain-dependent stimulation of growth in leptin-treated obese db/db mice. Endocrinology, 143, 3875-3883.
30. Kieffer,T.J., Heller,R.S., Leech,C.A., Holz,G.G. and Habener,J.F. (1997) Leptin suppression of insulin secretion by the activation of ATP-sensitive K+ channels in pancreatic beta-cells. Diabetes, 46, 1087-1093.
31. Barzilai,N., Wang,J., Massilon,D., Vuguin,P., Hawkins,M. and Rossetti,L. (1997) Leptin selectively decreases viscetal adiposity and enhances insulin action. J. Clin. Invest., 100, 3105-3110.
32. Shao,J., Yamashita,H., Qiao,L. and Friedman,J.E. (2000) Decreased Akt kinase activity and insulin resistance in C57BL/KsJ-Leprdb/db mice. J. Endocrinol., 167, 107-115.
33. Hu,F.B., Manson,J.E., Liu,S., Hunter,D., Colditz,G.A., Michels,K.B., Speizer,F.E. and Giovannucci,E. (1999) Prospective study of adult onset diabetes mellitus (type 2) and risk of colorectal cancer in women. J. Natl Cancer Inst., 91, 542-547.
34. Tran,T.T., Medline,A. and Bruce,W.R. (1996) Insulin promotion of colon tumors in rats. Cancer Epidemiol. Biomarkers Prev., 5, 1013-1015.
35. Giovannucci,E. (2001) Insulin, insulin-like growth factors and colon cancer: a review of the evidence. J. Nutr., 131, 3109S-3120S.
36. Moschos,S.J. and Mantzoros,C.S. (2002) The role of the IGF system in cancer: from basic to clinical studies and clinical applications. Oncology, 63, 317-332.
37. Macaulay,V.M. (1992) Insulin-like growth factors and cancer. Br. J. Cancer, 65, 311-320.
38. Moller,D.E. and Flier,J.S. (1991) Insulin resistance-mechanisms, syndromes and implications. N. Engl. J. Med., 325, 938-948.
39. Sandhu,M.S., Dunger,D.B. and Giovannucci,E.L. (2002) Insulin, insulin-like growth factor-I (IGF-I), IGF binding proteins, their biologic interactions and colorectal cancer. J. Natl Cancer Inst., 94, 972-980.
40. Guo,Y.S., Narayan,S., Yallampalli,C. and Singh,P. (1992) Characterization of insulin-like growth factor I receptors in human colon cancer. Gastroenterology, 102, 1101-1108.